References
- Gibbison B, Sheikh A, McShane P, Haddow C, Soar J. Anaphylaxis
admissions to UK critical care units between 2005 and 2009.
Anaesthesia. 2012;67:833–839.
- Lombardo C, Bonadonna P. Hypersensitivity Reactions to Proton Pump
Inhibitors. Curr Treat Options Allergy. 2015;2:110–123.
- Bonadonna P, Lombardo C, Bortolami O, Bircher A, Scherer K, Barbaud A,
et al. Hypersensitivity to proton pump inhibitors: diagnostic accuracy
of skin tests compared to oral provocation test. J Allergy Clin
Immunol. 2012;130:547–549.
- Ward RM, Kearns GL. Proton Pump Inhibitors in Pediatrics. Pediatr
Drugs. 2013;15:119–131.
- Thomson ABR, Sauve MD, Kassam N, Kamitakahara H. Safety of the
long-term use of proton pump inhibitors. World J Gastroenterol.
2010;16:2323–2330.
- Jordakieva G, Kundi M, Untersmayr E, Pali-Schöll I, Reichardt B,
Jensen-Jarolim E. Country-wide medical records infer increased allergy
risk of gastric acid inhibition. Nat Commun. 2019;10:3298.
- Attwood SE, Ell C, Galmiche JP, Fiocca R, Hatlebakk G, Hasselgren B,
et al. Long-term safety of proton pump inhibitor therapy assessed
under controlled, randomised clinical trial conditions: data from the
SOPRAN and LOTUS studies. Aliment Pharmacol Ther. 2015;41:1162–1174.
- Moayyedi P, Eikelboom JW, Bosch J, Connolly SJ, Dyal L, Shestakovska
O, et al. Safety of Proton Pump Inhibitors Based on a Large,
Multi-Year, Randomized Trial of Patients Receiving Rivaroxaban or
Aspirin. Gastroenterology. 2019;157:682-691.
- Strand DS, Kim D, Peura DA. 25 Years of Proton Pump Inhibitors: A
Comprehensive Review. Gut Liver. 2017;11:27-37.
- Baird AG, Lawrence JR. Guidelines: is bigger better? A review of SIGN
guidelines. BMJ Open. 2014;4:e004278.
- Scottish Intercollegiate Guidelines Network. SIGN 50: A guideline
developer’s handbook. Accessed September 1, 2022. Available at:
https://www.sign.ac.uk/our-guidelines/sign-50-a-guideline-developers-handbook/.
Edinburgh: SIGN; 2019.
- Diesner SC, Knittelfelder R, Krishnamurthy D, Pali-Schöll I, Gajdzik
L, Jensen-Jarolim E, et al. Dose-dependent food allergy induction
against ovalbumin under acid-suppression: a murine food allergy model.
Immunol Lett. 2008;121:45–51.
- Riemer AB, Gruber S, Pali-Schöll I, Kinaciyan T, Untersmayr E,
Jensen-Jarolim E. Suppression of gastric acid increases the risk of
developing immunoglobulin E-mediated drug hypersensitivity: human
diclofenac sensitization and a murine sensitization model. Clin Exp
Allergy. 2010;40:486–493.
- Mitre E, Susi A, Kropp LE, Schwartz DJ, Gotman GH, Nylund CM.
Association Between Use of Acid-Suppressive Medications and
Antibiotics During Infancy and Allergic Diseases in Early Childhood.
JAMA Pediatr. 2018;172:e180315.
- Ramírez E, Cabañas R, Laserna LS, Fiandor A, Tong H, Prior N, et al.
Proton pump inhibitors are associated with hypersensitivity reactions
to drugs in hospitalized patients: a nested case-control in a
retrospective cohort study. Clin Exp Allergy. 2013;43:344–352.
- Vega M, Alonso SB, España AP, Teruel SJQ, Fernández SF, Bermejo TB, et
al. Treatment with proton pump inhibitors as a cofactor in adverse
reactions of patients undergoing oral food immunotherapy:
Observational Study. Allergol Imunopathol (Madr). 2021;49:169-172.
- Kepil Özdemir S, Yılmaz I, Aydın O, Büyüköztürk S, Gelincik A,
Demirtürk M, et al. Immediate-type hypersensitivity reactions to
proton pump inhibitors: usefulness of skin tests in the diagnosis and
assessment of cross-reactivity. Allergy. 2013;68:1008–1014.
- Kepil Özdemir S, Öner Erkekol F, Ünal D, Büyüköztürk S, Gelincik A,
Dursun AB, et al. Management of Hypersensitivity Reactions to Proton
Pump Inhibitors: A Retrospective Experience. Int Arch Allergy Immunol.
2016;171:54-60.
- Laguna JJ, Bogas G, Salas M, Mayorga C, Dionicio J, Gonzalez-Mendiola
R, et al. The Basophil Activation Test Can Be of Value for Diagnosing
Immediate Allergic Reactions to Omeprazole. J Allergy Clin Immunol
Pract. 2018;6:1628-1636.
- Abdul Razzak E, Tomás M, Tornero P, Herrero T. Nine cases of allergy
to omeprazole. J Investig Allergol Clin Immunol. 2012;22:228–230.
- Gamboa PM, Sanz ML, Urrutia I, Jáuregui I, Antépara I, Diéguez I, et
al. CD63 expression by flow cytometry in the in vitro diagnosis of
allergy to omeprazole. Allergy. 2003;58:538–539.
- Lobera T, Navarro B, Del Pozo MD, González I, Blasco A, Escudero R, et
al.. Nine cases of omeprazole allergy: cross-reactivity between proton
pump inhibitors. J Investig Allergol Clin Immunol. 2009;19:57–60.
- Sánchez-Morillas L, Rojas Pérez-Ezquerra P, González Mendiola R,
Gómez-Tembleque Ubeda P, Santos Alvarez A, Laguna-Martínez JJ. Eleven
cases of omeprazole hypersensitivity: diagnosis and study of
cross-reactivity. J Investig Allergol Clin Immunol. 2014;24:130–132.
- Sobrevia Elfau MT, Garcés Sotillos M, Ferrer Clavería L, Segura
Arazuri N, Monzón Ballarin S, Colás Sanz C. Study of cross-reactivity
between proton pump inhibitors. J Investig Allergol Clin Immunol.
2010;20:157–161.
- Benito-Garcia F, Chambel M, Morais-Almeida M. Anaphylaxis due to
proton pump inhibitors: current understanding and important clinical
considerations. Expert Rev Clin Immunol. 2018;14:653–656.
- Safe M, Chan WH, Leach ST, Sutton L, Lui K, Krishnan U. Widespread use
of gastric acid inhibitors in infants: Are they needed? Are they safe?
World J Gastrointest Pharmacol Ther. 2016;7:531–539.
- Chang Y-S. Hypersensitivity reactions to proton pump inhibitors. Curr
Opin Allergy Clin Immunol. 2012;12:348–353.
- Otani IM, Banerji A. Immediate and Delayed Hypersensitivity Reactions
to Proton Pump Inhibitors: Evaluation and Management. Current Allergy
and Asthma Reports. 2016;16:17.
- Bose S, Guyer A, Long A, Banerji A. Evaluation and management of
hypersensitivity to proton pump inhibitors. Ann Allergy, Asthma
Immunol. 2013;111:452–457.
- Tayman C, Mete E, Catal F, Tonbul A. Hypersensitivity reaction to
omeprazole in a child. J Investig Allergol Clin Immunol.
2009;19:76–77.
- Reyes Balaguer J, Campos Andreu A, Hernández Fernández de Rojas D.
Anaphylaxis to proton pump inhibitors. Med Clin (Barc). 2007;128:799.
- Baldo BA, Pham NH. Chapter 11: Proton Pump Inhibitors. In: Baldo BA,
Pham NH, eds. Drug Allergy. Springer, Cham;2021:521-531.
- Savarino V, Di Mario F, Scarpignato C. Proton pump inhibitors in GORD
An overview of their pharmacology, efficacy and safety. Pharmacol Res.
2009;59:135-153.
- Kollmeier AP, Eddleston J, Zuraw BL, Christiansen SC. Recurrent
anaphylaxis linked to pantoprazole. J Allergy Clin Immunol.
2004;114:975-977.
- Shin JM, Kim N. Pharmacokinetics and pharmacodynamics of the proton
pump inhibitors. J Neurogastroenterol Motil. 2013;19:25-35.
- Cartee NMP, Wang MM. Binding of omeprazole to protein targets
identified by monoclonal antibodies. PLoS One. 2020;15:e0239464.
- González P, Soriano V, López P, Niveiro E. Anaphylaxis to proton pump
inhibitors. Allergol Immunopathol (Madr). 2002;30:342-343.
- Pérez-Ezquerra PR, Morillas LS, Martínez JJ, Fernández GD,
Gomez-Tembleque M del P, Alvarez AS, Sanz ML. Anaphylaxis to
omeprazole. Cross-reactivity with the other proton pump inhibitors.
Allergol Immunopathol (Madr). 2011;39:54.
- Vovolis V, Koutsostathis N, Stefanaki E. IgE-mediated anaphylaxis to
proton pump inhibitors - cross-reacting study. Allergy.
2008;63:1251-1252.
- Confino-Cohen R, Goldberg A. Anaphylaxis to omeprazole: diagnosis and
desensitization protocol. Ann Allergy Asthma Immunol. 2006;96:33-36.
- Garrido Fernández S, Cumplido JA, Rábano A, Martínez D, Blanco C,
Carrillo T. Allergy to proton pump inhibitors: diagnosis and
assessment of cross-reactivity. J Investig Allergol Clin Immunol.
2008;18:140-141.
- Porcel S, Rodríguez A, Jiménez S, Alvarado M, Hernández J. Allergy to
lansoprazole: study of cross-reactivity among proton-pump inhibitors.
Allergy. 2005;60:1087-1088.
- Galindo PA, Borja J, Feo F, Gómez E, García R, Cabrera M, et al.
Anaphylaxis to omeprazole. Ann Allergy Asthma Immunol. 1999;82:52-54.
- Natsch S, Vinks MH, Voogt AK, Mees EB, Meyboom RH. Anaphylactic
reactions to proton-pump inhibitors. Ann Pharmacother.
2000;34:474-476.
- Kepil Özdemir S, Gelincik A, Paksoy N, Köycü Buhari G, Öner Erkekol F,
Dursun AB, et al. Analysis of the factors associated with diagnostic
skin test positivity in immediate-type hypersensitivity reactions due
to proton pump inhibitors. Allergy. 2019;74:1187-1190.
- Casciaro M, Navarra M, Inferrera G, Liotta M, Gangemi S, Minciullo PL.
PPI adverse drugs reactions: a retrospective study. Clin Mol Allergy.
2019;17:1.
- Kepil Özdemir S, Bavbek S. Hypersensitivity reactions to proton-pump
inhibitors: Clinical presentation, diagnosis, and management. Allergy
Asthma Proc. 2020;41:e37-e44.
- Haeney MR. Angio-edema and urticaria associated with omeprazole. BMJ
1992;305:870.
- Bowlby HA, Dickens GR. Angioedema and urticaria associated with
omeprazole confirmed by drug rechallenge. Pharmacotherapy.
1994;14:119-122.
- Ottervanger JP, Phaff RA, Vermeulen EG, Stricker BH. Anaphylaxis to
omeprazole. J Allergy Clin Immunol. 1996;97:1413-1414.
- Molinero MA, Ballesteros del Río B, de Paz FN, Pérez EF. Immediate
anaphylactic shock after the administration of intravenous omeprazol.
Rev Clin Esp. 2003;203:216-217.
- Ricciardi L, Fedele R, Mazzeo L, Saitta S, Mancuso V, Isola S. Adverse
reactions to pantoprazole. Scand J Gastroenterol. 2003;38:800.
- Vovolis V, Christogianni K, Koutsostathis N. Immunoglobulin E-mediated
anaphylaxis to rabeprazole. J Investig Allergol Clin Immunol.
2010;20:360-361.
- Brockow K, Romano A, Blanca M, Ring J, Pichler W, Demoly P. General
considerations for skin test procedures in the diagnosis of drug
hypersensitivity. Allergy. 2002;57:45-51.
- Stefanaki EC, Vovolis V, Letsa I, Koutsostathis N. Anaphylactic
reaction to omeprazole. Am J Gastroenterol. 2008;103:1581-1583.
- Perez Pimiento AJ, Prieto Lastra L, Rodrıguez Cabreros MI, Gonzalez
Sanchez LA, Mosquera MR, Garcia Cubero A. Hypersensitivity to
lansoprazole and rabeprazole with tolerance to other proton pump
inhibitors. J Allergy Clin Immunol. 2006;117:707–708.
- Tourillon C, Mahe J, Baron A, Lambert A, Yélehé-Okouma M, Veyrac G,
Jolliet P. Immediate-Type Hypersensitivity Cross-Reactions to Proton
Pump Inhibitors: A Descriptive Study of Data from the French National
Pharmacovigilance Database. Int Arch Allergy Immunol.
2019;178:159-166.
- Aksu K, Kurt E. Anaphylaxis to lansoprazole with tolerance to
omeprazole. Allergol Immunopathol (Madr).2012;40:393-394.
- Choi SW, Han JM, Bae YJ, Lee YS, Cho YS, Moon HB, Kim TB. Lessons from
two cases of anaphylaxis to proton pump inhibitors. J Clin Pharm Ther.
2012;37:614-616.
- Karabacak E, Kutlu A, Aydin E, Ozturk S. Hypersensitivity to
lansoprazole with tolerance to other proton pump inhibitors: does
cross-reactivity between proton pump inhibitors really exist? Allergol
Immunopathol (Madr). 2013;41:136-137.
- Turedi O, Sozener ZC, Kendirlinan R, Bavbek S. A Case of Pantoprazole
Anaphylaxis with Cross Reactivity to All Proton Pump Inhibitors:
Finding a Safe Alternative. Curr Drug Saf. 2017;12:198-200.
- Mayorga C, Celik G, Rouzaire P, Whitaker P, Bonadonna P,
Rodrigues-Cernadas J,et al. In vitro tests for drug hypersensitivity
reactions: an ENDA/EAACI Drug Allergy Interest Group position paper.
Allergy. 2016;71:1103-1134.
- Mota I, Gaspar Â, Chambel M, Morais-Almeida M. Anaphylaxis induced by
proton pump inhibitors. J Allergy Clin Immunol Pract. 2016;4:535–536.
- Demirkan K, Bozkurt B, Karakaya G, Kalyoncu AF. Anaphylactic reaction
to drugs commonly used for gastrointestinal system diseases: 3 case
reports and review of the literature. J Investig Allergol Clin
Immunol. 2006;16:203–209.
- Pita JS, Azevedo J, Fernandes RA, Loureiro C, Bom AT.
Immediate-hypersensitivity reactions to proton pump inhibitors:
Experience in a medical department. Ann Allergy Asthma Immunol.
2019;122:204-205.
- Kara M, Tanoglu A, Kutlu A, Sirkeci O, Kekilli M. Esomeprazole: a safe
alternative to lansoprazole allergy? Iran J Allergy Asthma Immunol.
2014;13:296-297.
- Fardet L, Izzedine H, Ciroldi M, Tiev KP, Cabane J.
Pantoprazole-induced recurrent anaphylactic shock. Am J Gastroenterol.
2002;97:2933.
- Canpolat U, Şahiner L, Aytemir K, Oto A. Allergic reaction to proton
pump inhibitor: pantoprazole induced Kounis syndrome. Int J Cardiol.
2012;159:e27-e28.
- González-Rubio F, Esteban-Jiménez O, Garcés-Sotillos MD, Colás-Sanz C.
Anaphylactic shock due to omeprazole.Gastroenterol Hepatol.
2017;40:20-21.
- Yıldız E, Çölkesen F, Sadi Aykan F, Evcev R, Kılınç M, Aytekin G,
Arslan Ş. Successful Oral Desensitization to Rabeprazole: A Case
Report of a Patient with Duodenal Ulcer. Asthma Allergy Immunol.
2022;20:120-123.
- Lin CY, Wang CW, Hui CR, Chang YC, Yang CH, Cheng CY, et al.
Delayed-type hypersensitivity reactions induced by proton pump
inhibitors: A clinical and in vitro T-cell reactivity study. Allergy.
2018; 73:221–229.
- Hammami S, Affes H, Ksouda K, Feki M, Sahnoun Z, Zeghal KM. Étude de
l’allergie croisée entre les différents inhibiteurs de la pompe à
protons [Study of cross reactivity between proton pump
inhibitors]. Therapie. 2013;68:361-368.
- Morais P, Baudrier T, Mota A, Cunha AP, Cadinha S, Barros AM, Azevedo
F. Nonpigmented fixed drug eruption induced by esomeprazole. Cutan
Ocul Toxicol. 2010;29:217-220.
- Raison-Peyron N, Minh HB, Peyron JL, Demoly P, Guillot B. Toxidermie
photodistribuée induite par les inhibiteurs de la pompe à protons
[Photodistributed cutaneous drug reaction induced by proton pump
inhibitors]. Therapie. 2005;60:85-87.
- Caboni S, Gunera-Saad N, Ktiouet-Abassi S, Berard F, Nicolas JF.
Esomeprazole-induced DRESS syndrome. Studies of cross-reactivity among
proton-pump inhibitor drugs. Allergy. 2007;62:1342-1343.
- Barbaud A, Collet E, Milpied B, Assier H, Staumont D, Avenel-Audran M,
et al; Toxidermies group of the French Society of Dermatology. A
multicentre study to determine the value and safety of drug patch
tests for the three main classes of severe cutaneous adverse drug
reactions. Br J Dermatol. 2013;168:555-562.
- Nantes Castillejo O, Zozaya Urmeneta JM, Valcayo Peñalba A,
Martínez-Peñuela Virseda JM. Pustulosis exantemática aguda
generalizada inducida por omeprazol [Acute generalized exanthematous
pustulosis induced by omeprazole]. Gastroenterol Hepatol.
2008;31:295-298.
- Schmitz B, Sorrells T, Glass JS. Acute generalized exanthematous
pustulosis caused by pantoprazole. Cutis. 2018;101:e22-e23.
- Heaton NR, Edmonds EV, Francis ND, Bunker CB, Bowling JC, Morar N.
Fatal toxic epidermal necrolysis due to lansoprazole. Clin Exp
Dermatol. 2004;29:612-613.
- Fracaroli TS, Miranda LQ, Sodré JL, Chaves M, Gripp A. Toxic epidermal
necrolysis induced by lansoprazole. An Bras Dermatol. 2013;88:117-120.
- Casacci M, Lebas D, Decamps F, Fourrier F, Delaporte E. Toxic
epidermal necrolysis due to omeprazole. Eur J Dermatol.
2006;16:699-700.
- Thakor AS, Burke A, Handfield-Jones S, Sinha A, Palmer M, Burns A.
Toxic epidermal necrolysis and neutropaenia: complications of
omeprazole. Australas J Dermatol. 2009;50:207-210.
- Brajon D, Menetre S, Waton J, Poreaux C, Barbaud A. Non-irritant
concentrations and amounts of active ingredient in drug patch tests.
Contact Dermatitis. 2014;71:170-175.
- Barbaud A, Castagna J, Soria A. Skin tests in the work-up of cutaneous
adverse drug reactions: A review and update. Contact Dermatitis.
2022;86:344-356.
- Kim D, Kang H. Proton pump inhibitor-induced vitiligo following
airborne occupational sensitization. Contact Dermatitis.
2021;85:595-596.
- DeKoven JG, Yu AM. Occupational Airborne Contact Dermatitis From
Proton Pump Inhibitors. Dermatitis. 2015;26:287-290.
- Ghatan PH, Marcusson-Ståhl M, Matura M, Björkheden C, Lundborg P,
Cederbrant K. Sensitization to omeprazole in the occupational setting.
Contact Dermatitis. 2014;71:371-375.